PRDS DATA Tel: 185-1234-5678 页头:登录 | 页头:注册

GLENMARK LIFE SCIENCES LIMITED(BSE:GLS)

{{price.price}} INR
{{price.change}}%
{{price.high}} 11298 6% 34.49
{{price.low}} 12267368 31.48% 1335
{{price.open}} 0.93% 19.21% 666
{{price.close}} 2.06 8912370000% 133046185156
8.57 7.18 -3.34 27.46
8.24 44.61 44.56 44.56
3.68 4.65 4.18 11298
43332 73592 符号详情:1天涨跌率 0.93 7.39
10.5 10 74 103
1098 1000 1003 6242.1
4489.27 6715.52 12898.43 2.11
2.06 -1.06 2.09 2.1
1.52 0.26 940 935
821 369 666 1098
1163 1335 1335 1335
38.43 34.56 4708880000 4235010000
2041510000 7403780000 8912370000 10
7.75 38.38 34.49 5506550000
22702150000 22048960000
2965450000
-4303150000 25384800000
4462920000 3015940000 4462920000 3015940000
20960580000 5226400000 4637340000 4637340000
159770000 30848590000 128743035156 29.92
20.74
19.21 32.61 40.42 21.07
17.18 27.32 24.97
Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

http://www.glenmarklifesciences.com

Yasir Rawjee

2011

Mumbai

Health technology

Pharmaceuticals: major